4.7 Review

Differential Gene Expression of Subcutaneous Adipose Tissue among Lean, Obese, and after RYGB (Different Timepoints): Systematic Review and Analysis

Journal

NUTRIENTS
Volume 14, Issue 22, Pages -

Publisher

MDPI
DOI: 10.3390/nu14224925

Keywords

obesity; subcutaneous adipose tissue; RYGB; gene expression; gene candidate; transcriptome

Funding

  1. Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [IA203919]
  2. Direccion General de Asuntos del Personal Academico (DGAPA)/Universidad Nacional Autonoma de Mexico (UNAM)
  3. Division de Investigacion de la Facultad de Medicina, UNAM
  4. CONACyT-FOSSIS [289699]
  5. Hospital Infantil de Mexico Federico Gomez [HIM/2018/028 SSA. 1494]

Ask authors/readers for more resources

The main roles of adipose tissue are to store triglycerides and secrete adipokines, which regulate energy balance and inflammation. In obesity, dysfunction of adipocytes leads to inflammation and insulin resistance. This systematic review aimed to identify differentially expressed genes in subcutaneous adipose tissue of lean, obese, and post-RYGB individuals. The results showed that both the lean state and post-RYGB are similar in terms of increased expression of insulin-sensitizing molecules, promoting lipogenesis over lipolysis, and downregulating factors that promote inflammation.
The main roles of adipose tissue include triglycerides storage and adipokine secretion, which regulate energy balance and inflammation status. In obesity, adipocyte dysfunction leads to proinflammatory cytokine production and insulin resistance. Bariatric surgery is the most effective treatment for obesity, the gold-standard technique being Roux-en-Y gastric bypass (RYGB). Since metabolic improvements after RYGB are clear, a better understanding of adipose tissue molecular modifications could be derived from this study. Thus, the aim of this systematic review was to find differentially expressed genes in subcutaneous adipose tissue of lean, obese and post-RYGB (distinct timepoints). To address this objective, publications from 2015-2022 reporting gene expression (candidate genes or transcriptomic approach) of subcutaneous adipose tissue from lean and obese individuals before and after RGYB were searched in PubMed, Elsevier, and Springer Link. Excluded publications were reviews, studies analyzing serum, other types of tissues, or bariatric procedures. A risk-of-bias summary was created for each paper using Robvis, to finally include 17 studies. Differentially expressed genes in post-RYGB vs. obese and lean vs. obese were obtained and the intersection among these groups was used for analysis and gene classification by metabolic pathway. Results showed that the lean state as well as the post-RYGB is similar in terms of increased expression of insulin-sensitizing molecules, inducing lipogenesis over lipolysis and downregulating leukocyte activation, cytokine production and other factors that promote inflammation. Thus, massive weight loss and metabolic improvements after RYGB are accompanied by gene expression modifications reverting the adipocyte dysfunction phenomenon observed in obesity conditions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available